title: Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).
authors.forename: D G
authors.initials: DG
authors.lastname: Evans
authors.forename: V
authors.initials: V
authors.lastname: Newton
authors.forename: W
authors.initials: W
authors.lastname: Neary
authors.forename: M E
authors.initials: ME
authors.lastname: Baser
authors.forename: A
authors.initials: A
authors.lastname: Wallace
authors.forename: R
authors.initials: R
authors.lastname: Macleod
authors.forename: J P
authors.initials: JP
authors.lastname: Jenkins
authors.forename: J
authors.initials: J
authors.lastname: Gillespie
authors.forename: R T
authors.initials: RT
authors.lastname: Ramsden
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001300:Audiometry, Evoked Response; D001301:Audiometry, Pure-Tone; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000235:genetics; D002648:Child; D005820:Genetic Testing; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D016518:Neurofibromatosis 2 / Q000175:diagnosis* / Q000235:genetics; D011446:Prospective Studies; D012307:Risk Factors; D015898:Tomography Scanners, X-Ray Computed